Efficacy of long-term azathioprine for relapsing nephrotic syndrome

Pediatric Nephrology

Volumn 14, Issue 8-9, 2000, Pages 776-778

  Hiraoka, Masahiro ^a   Tsukahara, Hirokazu ^a   Hori, Chikahide ^a   Ohshima, Yusei ^a   Momoi, Toru ^b   Seo, Akihiko ^a   Mayumi, Mitsufumi ^a  

^a University of Fukui   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Azathioprine; Cyclophosphamide; Frequent relapses; Nephrotic syndrome (childhood)

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; LONG TERM CARE; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RELAPSE;

EID: 0033914268     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00013436     Document Type: Article

References (16)

1. Nash M, Edelmann C, Burnstein J, Barnett H (1992) Minimal change nephrotic syndrome, diffuse mesangial hypercellularity, and focal glomerular sclerosis. In: Edelmann C (ed) Pediatric kidney disease. Little Brown, Boston, pp 1267-1290
2. Brodehl J (1991) Conventional therapy for idiopathic nephrotic syndrome in children. Clin Nephrol 35:8-15
3. Niaudet P, Broyer M, Habib R (1991) Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 35:31-36
4. Yoshikawa N, Tanaka R, Kitano Y, Nakamura H, Ito H (1995) Long-term cyclosporin in steroid-dependent nephrotic syndrome. Contrib Nephrol 114:19-27
5. Hazleman B (1982) The comparative incidence of malignant disease in rheumatoid arthritis exposed to different treatment regimens. Ann Rheum Dis 41:12-17
6. Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M (1999) Controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 10:101-109
7. Hollander AA, Saase J van, Kootte AM, Dorp WT van, Bockel HJ van, Es LA van, Woude FJ van der ( 1995) Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 345:610-614
8. Abramowicz M, Arneil G, Barnett H, Barron BA, Edelmann CM, Gordillo-P G, Greifer I, Hallman N, Kobayashi O, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. Lancet I:959-961
9. Cade R, Mars D, Privette M, Thompson R, Croker D, Peterson J, Campbell K (1986) Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. Arch Intern Med 146:737-741
10. Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B (1997) Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 10:136-145
11. International Study of Kidney Diseases in Children (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 20:765-771
12. Ueda N, Chihara M, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Ohnishi M, Yasaki T (1988) Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. J Pediatr 112:122-126
13. Barratt TM, Cameron JS, Chantler C, Counahan R, Ogg CS, Soothill JF (1977) Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood. Arch Dis Child 52:462-463
14. Taube D, Brown Z, Williams D (1981) Long-term impairment of suppressor-cell function by cyclophosphamide in minimal change-nephropathy and its association with therapeutic response. Lancet I:235-238
15. Takeda A, Ohgushi H, Niimura F, Matsutani H (1998) Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome. Pediatr Nephrol 12:746-750
16. Katz, P, Fauci A (1995) Drugs that regulate the immune response In: Frank M, Austen KF, Claman H, Unanue E (eds) Samter's immunologic diseases, 5th edn, vol 2. Little Brown, Boston, pp 1511-1528